secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2024-08-26T23:59:59+00:00
Accession:  0000950170-24-100550
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences raises ~$3.8M via warrant exercises; issues new warrants
-------------------------------------------------------------------------------

- Class D warrant holders exercise 2,548,060 shares at reduced price of $1.50/share, gross proceeds ~$3.8M.
- New Inducement Warrants issued to purchase up to 5,096,120 shares at $1.00/share, exercisable for 5 years.
- Net proceeds to fund GEM-AKI, GEM-CKD, GEM-PSI clinical trials and working capital.
- Roth Capital Partners paid ~$267,546 advisory fee; exercise prices of certain Class C/D warrants adjusted to $1.00.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024100550/0000950170-24-100550-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017024100550/revb-20240821.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-100550

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer